NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 324 filers reported holding NOVAVAX INC in Q2 2022. The put-call ratio across all filers is 1.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,148,828 | +7.5% | 434,921 | +10.3% | 0.01% | 0.0% |
| Q2 2023 | $2,929,292 | +90.6% | 394,252 | +1219.4% | 0.01% | +400.0% |
| Q2 2022 | $1,537,000 | -71.0% | 29,882 | -58.4% | 0.00% | -75.0% |
| Q1 2022 | $5,292,000 | +73.1% | 71,862 | +239.7% | 0.00% | +100.0% |
| Q4 2021 | $3,058,000 | -89.3% | 21,154 | -84.6% | 0.00% | -90.9% |
| Q3 2021 | $28,532,000 | +171.1% | 137,624 | +177.7% | 0.02% | +144.4% |
| Q2 2021 | $10,523,000 | -28.9% | 49,566 | -39.3% | 0.01% | -35.7% |
| Q1 2021 | $14,806,000 | +452.3% | 81,661 | +239.6% | 0.01% | +366.7% |
| Q4 2020 | $2,681,000 | +681.6% | 24,044 | +660.4% | 0.00% | – |
| Q3 2020 | $343,000 | – | 3,162 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,559,918 | $543,496,000 | 8.72% |
| Foresite Capital Management I, LLC | 66,810 | $14,184,000 | 8.55% |
| Samsara BioCapital, LLC | 198,600 | $42,165,000 | 5.20% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 330,541 | $70,177,000 | 4.54% |
| Foresite Capital Management II, LLC | 67,373 | $14,304,000 | 3.85% |
| Rock Springs Capital Management LP | 455,000 | $96,601,000 | 1.91% |
| DELTEC ASSET MANAGEMENT LLC | 56,320 | $11,957,000 | 1.65% |
| Parametrica Management Ltd | 10,200 | $2,166,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 88,450 | $18,779,000 | 1.52% |
| TSP Capital Management Group, LLC | 18,525 | $3,933,000 | 1.29% |